Dr Stoyan Radkov

Patent Director

Stoyan focuses exclusively on the biotechnology and pharmaceutical fields and his clients benefit from his extensive private practice and in-house experience. 

Stoyan has a First Class Honours Degree in Microbiology from the University of Reading and after a PhD in Viral Oncology at the Ludwig Institute for Cancer Research, he had a successful career as a senior scientist at Imperial College London and UCL. 

Stoyan trained at a top tier London IP firm before moving in-house to Pfizer in Sandwich, UK and then Novartis and Syngenta in Basel, Switzerland. His scientific findings have been published in Nature Medicine and Journal of Virology. 

Stoyan was recognised in Legal 500 in 2015 for his expertise "...in high-value oppositions and appeals at the EPO, representing clients from the biotech and life sciences industries".